Melanie Peck

MCB graduate student & Innovation PhD fellow

 

Melanie Peck is a Ph.D. candidate in Molecular and Cellular Biology at Dartmouth College in Dr. Yina Huang’s lab. Her research focuses on advancing the lab’s novel nanoparticle-ribocytokine intratumoral immunotherapy toward clinical translation. She works closely on IND-enabling studies that support the development of this therapy for an investigator-initiated Phase I clinical trial. Before coming to Dartmouth, Melanie earned her Bachelor of Medical Sciences in Interdisciplinary Medical Sciences from Western University. Since 2022, she has also been involved in biotechnology entrepreneurship and commercialization through the Dartmouth Innovation PhD Fellowship, the Dartmouth Innovation Accelerator for Cancer, and her role as Co-President of the Dartmouth Biotechnology Club.

Publication

Mohamed AO, Boone, DT, Ferry SL, Peck MC, Santos AM, Soderholm HE, Wittling MC, Paulos C, Turk MJ, Huang YH. CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors. J Immunother Cancer 2025 Feb 11;13(2):e009994. doi: 10.1136/jitc-2024-009994. PMID: 39933839.